Home Overview Press Room Blog Publications For Students about us

Biotech & Pharma : Displaying 11-20 of 2169

Theranos isnít the only diagnostics company exploiting regulatory loopholesby Arielle Duhaime-RossThe VergeNovember 11th, 2015Startups are taking advantage of an FDA exception to offer diagnostic health tests to consumers without peer review or verification of health claims.
Gene therapies offer dramatic promise but shocking costsby Carolyn Y. Johnson & Brady DennisThe Washington PostNovember 11th, 2015Researchers have partially restored a patient's vision by targeting a gene associated with Leber's congenital amaurosis, but the treatment could cost $500,000 per eye.
The Risks of Assisting Evolutionby Elizabeth AlterThe New York TimesNovember 10th, 2015Crispr-Cas9 and gene drive allow us to bend evolution to our will, but will they spark an ecological catastrophe?
British police face deluge of foreign DNA requests if UK joins EU crime database, says reportby David BarrettThe TelegraphNovember 8th, 2015Officials warn that innocent Britons could be branded criminals if the UK joins a controversial EU project.
Eggs unlimitedby Jennifer Couzin-FrankelScienceNovember 6th, 2015OvaScience's fertility procedure appalls some reproductive biologists, and is currently not permitted in the US. But the company is marketing its treatment in Canada and some analysts are upbeat.
[UK] Baby girl is first in the world to be treated with 'designer immune cells'by Ian SampleThe GuardianNovember 5th, 2015Genetically engineered cells were used to successfully treat an aggressive form of childhood leukaemia, though the experimental treatment had only been tested on mice.
As Companies Collect More Health Data, Cops Will Ask To See It[cites CGS's Elliot Hosman]by Stephanie M. LeeBuzzfeedNovember 5th, 2015Law enforcement will request what users share with health technology companies, from DNA to step counts. The nature and number of those requests are largely unknown.
CRISPR Gene Editing to Be Tested on People by 2017, Says Editasby Antonio RegaladoMIT Technology ReviewNovember 5th, 2015The test, to treat a rare form of blindness, would likely be the first to use CRISPR to directly edit the DNA of a person.
Everything you need to know about why CRISPR is such a hot technology[cites CGS]by Dominic BasultoThe Washington PostNovember 4th, 2015Venture capital is responding to the hype surrounding new genetic engineering tools, but many are concerned by the controversial proposition of genetically modifying new humans.
How Much Should a Woman Be Paid for Her Eggs?by Jacoba UristThe AtlanticNovember 4th, 2015Is the money a woman receives for her eggs payment for her services, her discomfort, or her biological property?
Displaying 11-20 of 2169  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760